• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Conjugation to polymeric chains of influenza drugs targeting M2 ion channels partially restores inhibition of drug-resistant mutants

tetano

Editor, Senior Moderator
J Pharm Sci. 2013 Jul 6. doi: 10.1002/jps.23644. [Epub ahead of print]
Conjugation to polymeric chains of influenza drugs targeting M2 ion channels partially restores inhibition of drug-resistant mutants.
Larson AM, Chen J, Klibanov AM.
Source

Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Abstract

By attaching multiple copies of the influenza M2 ion channel inhibitors amantadine (1) and rimantadine (2) to polymeric chains, we endeavored to recover their potency in inhibiting drug-resistant influenza viruses. Depending on loading densities, as well as the nature of the drug, the polymer, and the spacer arm, polymer-conjugated drugs were up to 30-fold more potent inhibitors of drug-resistant strains than their monomeric parents. In particular, a 20% loading density and a short linker group on the negatively charged poly-l-glutamate resulted in one of the most potent inhibitors for 2's conjugates against drug-resistant influenza strains. Although full recovery of the inhibitory action against drug-resistant strains was not achieved, this study may be a step toward salvaging anti-influenza drugs that are no longer effective. ? 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci.

Copyright ? 2013 Wiley Periodicals, Inc.
KEYWORDS:

antiinfectives, biodegradable polymers, conjugation, drug resistance, inhibition, polymeric drug carrier, polymeric drugs, polymers

PMID:
23832466
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23832466
 
Back
Top Bottom